drugset / Trial / NCT02422602

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program

NCT02422602

Completed 196 enrolled University Hospital, Montpellier
RandomizedParallel-groupSingle-blindSupportive care

Summary

This study is multicentric, single-blind, and interventional with a randomization into two parallel arm, between a standard of care information and an additional information of the patient, with a 12 month follow up. The aim of this study is to evaluate the effectiveness of a personalized information program versus information provided from standard of care in patients taking Xarelto for Stroke Prevention in Atrial Fibrillation.

Timeline

Start
2013-11-26
Primary completion
2015-05-06
Completion
2016-05-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rivaroxaban Other / unclassified Oral

Indications